𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: Comment on the article by Hoffman et al

✍ Scribed by Juan Angel Jover; Cesar Hernández-Garcia; Inmaculada C. Morado; Emilio Vargas; Antonio Bañares; Benjamin Fernandez-Gutierrez

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
209 KB
Volume
48
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucocorticoid therapy in giant cell art
Glucocorticoid therapy in giant cell arteritis: Comment on the article by Prøven et al
✍ Docken, William P. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

The recent article by Prøven et al (Prøven A, Gabriel S, Orces C, O'Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003;49:703-8) emphasizes the toxicities inherent in the use of high-dose steroids for the management of giant cell

Differences between active treatment and
Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: Comment on the article by Mazlumzadeh et al
✍ Ana M. Bertoli; Yvonne M. Font; Anaida Nadal; Luis M. Vilá 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB 👁 2 views

We read with great interest the article by Mazlumzadeh M et al addressing the effectiveness and safety of induction therapy with high-dose pulse intravenous methylprednisolone in giant cell arteritis (GCA) (1). The results of that trial provide a rationale for the use of this treatment approach, whi